Cite
HARVARD Citation
Salas, M. et al. (2021). Lower dose of ATG combined with post-transplant cyclophosphamide for HLA matched RIC alloHCT is associated with effective control of GVHD and less viral infections. Leukemia & lymphoma. 62 (14), pp. 3373-3383. [Online].